Cognitive behavior therapy for hypochondriasis: a randomized controlled trial
- PMID: 15039413
- DOI: 10.1001/jama.291.12.1464
Cognitive behavior therapy for hypochondriasis: a randomized controlled trial
Abstract
Context: Hypochondriasis is a chronic, distressing, and disabling condition that is prevalent in ambulatory medical practice. Until recently, no specific treatment has been clearly demonstrated to be effective.
Objective: To assess the efficacy of a cognitive behavior therapy (CBT) for hypochondriasis.
Design: A randomized, usual care control group design, conducted between September 1997 and November 2001. The individual primary care physician was the unit of randomization, and all patients clustered within each physician's practice were assigned to the experimental treatment (individual CBT and a consultation letter to the primary care physician) or to the control condition. Subjects were assessed immediately before and 6 and 12 months after the completion of treatment.
Setting and participants: Participants were 80 patients from primary care practices and 107 volunteers responding to public announcements, all of whom exceeded a predetermined cutoff score on a hypochondriasis self-report questionnaire on 2 successive occasions.
Intervention: A scripted, 6-session, individual CBT intervention was compared with medical care as usual. The CBT was accompanied by a consultation letter sent to the patient's primary care physician.
Main outcome measures: Hypochondriacal beliefs, fears, attitudes, and somatic symptoms; role function and impairment.
Results: A total of 102 individuals were assigned to CBT and 85 were assigned to medical care as usual. The sociodemographic and clinical characteristics of the 2 groups were similar at baseline. Using an intent-to-treat analytic strategy, a consistent pattern of statistically and clinically significant treatment effects was found at both 6- and 12-month follow-up, adjusting for baseline covariates that included educational level, generalized psychiatric distress, and participant status (patient vs volunteer). At 12-month follow-up, CBT patients had significantly lower levels of hypochondriacal symptoms, beliefs, and attitudes (P<.001) and health-related anxiety (P =.009). They also had significantly less impairment of social role functioning (P =.05) and intermediate activities of daily living (P<.001). Hypochondriacal somatic symptoms were not improved significantly by treatment.
Conclusion: This brief, individual CBT intervention, developed specifically to alter hypochondriacal thinking and restructure hypochondriacal beliefs, appears to have significant beneficial long-term effects on the symptoms of hypochondriasis.
Comment in
-
Interventions for hypochondriasis in primary care.JAMA. 2004 Jul 7;292(1):42; author reply 42-3. doi: 10.1001/jama.292.1.42-a. JAMA. 2004. PMID: 15238587 No abstract available.
-
Cognitive behavioural therapy significantly improves hypochondriacal symptoms.Evid Based Ment Health. 2004 Nov;7(4):118. doi: 10.1136/ebmh.7.4.118. Evid Based Ment Health. 2004. PMID: 15504806 No abstract available.
Similar articles
-
Responsiveness of hypochondriacal patients with chronic low-back pain to cognitive-behavioral therapy.Psychosomatics. 2012 Mar-Apr;53(2):139-47. doi: 10.1016/j.psym.2011.09.006. Psychosomatics. 2012. PMID: 22424162 Clinical Trial.
-
Effectiveness and cost offset analysis of group CBT for hypochondriasis delivered in a psychiatric setting: an open trial.Cogn Behav Ther. 2010;39(4):239-50. doi: 10.1080/16506073.2010.496460. Cogn Behav Ther. 2010. PMID: 20972912 Clinical Trial.
-
Clinical effectiveness of individual cognitive behavioral therapy for depressed older people in primary care: a randomized controlled trial.Arch Gen Psychiatry. 2009 Dec;66(12):1332-40. doi: 10.1001/archgenpsychiatry.2009.165. Arch Gen Psychiatry. 2009. PMID: 19996038 Clinical Trial.
-
Mindfulness and bodily distress.Dan Med J. 2012 Nov;59(11):B4547. Dan Med J. 2012. PMID: 23171754 Review.
-
Hypochondriasis and somatization.JAMA. 1987 Nov 20;258(19):2718-22. JAMA. 1987. PMID: 3312664 Review.
Cited by
-
The Central Sensitization Inventory Measures Thoughts and Emotions.J Patient Exp. 2024 Aug 14;11:23743735241273589. doi: 10.1177/23743735241273589. eCollection 2024. J Patient Exp. 2024. PMID: 39148748 Free PMC article.
-
The Moderating Role of Intolerance of Uncertainty in the Relationship Between Health Anxiety and Pandemic-Related Stress.Cognit Ther Res. 2023;47(3):340-349. doi: 10.1007/s10608-023-10365-w. Epub 2023 Mar 20. Cognit Ther Res. 2023. PMID: 37168694 Free PMC article.
-
Putative risk and resiliency factors among Royal Canadian Mounted Police cadets.Front Psychol. 2023 Mar 15;14:1048573. doi: 10.3389/fpsyg.2023.1048573. eCollection 2023. Front Psychol. 2023. PMID: 37008880 Free PMC article.
-
Health Anxiety by Proxy Disorder: A Case Report.Cureus. 2023 Jan 22;15(1):e34058. doi: 10.7759/cureus.34058. eCollection 2023 Jan. Cureus. 2023. PMID: 36824537 Free PMC article.
-
The 14-item short health anxiety inventory (SHAI-14) used as a screening tool: appropriate interpretation and diagnostic accuracy of the Swedish version.BMC Psychiatry. 2022 Nov 14;22(1):701. doi: 10.1186/s12888-022-04367-3. BMC Psychiatry. 2022. PMID: 36376898 Free PMC article.
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
